Improving healthcare in UP govt hosps: Facility heads instructed to take rounds, click picture & upload
Heads of all government hospitals have been directed to take rounds of wards before OPD starts in the morning and in the evening, interact with patients, check the quality of food being served, and check the functioning of services at all counters on the hospital campus.
In a letter issued by principal secretary, medical and health, Partha Sarthi Sen Sharma, to all chief medical superintendents of government hospitals, the doctors have been instructed, 'To click pictures of rounds taken and upload the same on WhatsApp group.'
'For making patients comfortable in hospital and for a better image of the facility, it is significant that staff behaviour is good and services are provided. Speaking with a few patients will help understand their issues and they can be resolved too.'
Checking of patient care services is to be done regularly. Get the food supplied to patients tested by the Food Safety and Drug Administration (FDA) officials, the doctors have been told.
Check if the hospital staff is forcing patients to purchase medicines or any other consumable from outside stores, the letter instructs the hospital incharges.
During summer, functioning of air coolers and water coolers should be checked along with electrical fitting and wiring. During the rounds take supervisors of outsourcing agencies along, so that issues concerning them are resolved.
'If the hospital in-charge is not present, the next senior most doctors should take the round,' said Sen Sharma, who is also principal secretary medical education.
Members of the Rogi Kalyan Samiti shall be included while on the rounds and their recommendations be forwarded to director-general, medical and health, or director, medical care via additional director, health, the letter instructs.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NDTV
2 hours ago
- NDTV
Shefali Jariwala Death Puts The Spotlight On How Youth Is The New Status Symbol
In the 1890s, renowned Irish author, poet, and playwright Oscar Wilde published his novel The Picture of Dorian Gray. The story revolves around a handsome but narcissistic man named Dorian Gray, who barters his soul to preserve his youthful appearance. While he remains outwardly beautiful, his inner self becomes increasingly corrupted by vanity and hedonism. The decay of his soul is revealed only in a painted portrait that reflects the consequences of his actions. Cut to almost five decades later, the book still remains relevant and raises a question that continues to haunt us. How far are you willing to go to look a certain way? Oscar Wilde's novel might have painted a dystopian world for his time, but today, it feels like we're living it. Youth, looking young, having a baby face, and ageing slowly seems to be the latest obsession for the elite, and there's no stopping it. Now, we're not saying that taking care of yourself is bad, but when it turns into an obsession like Dorian's, we might end up like him: dead. How Youth Is Becoming The Ultimate Status Symbol The death of actor-model Shefali Jariwala on June 27 has raised several questions. According to sources, one possible cause of her heart attack could be anti-ageing injections like glutathione and Vitamin C, which she may have taken while fasting - causing a drop in her blood pressure and leading to cardiac arrest. These drugs are neither FDA- nor Central Drugs Standard Control Organisation-approved for skin whitening, brightening or anti-ageing. Shefali's death has once again spotlighted the harsh beauty standards women are held against. In the 21st century, beauty doesn't lie in the eyes of the beholder - it lies in the hands of doctors. Biohacking. Supplements. Anti-ageing drugs. These terms have gained momentum over the past few years. Looking and feeling young is becoming the ultimate status symbol. From Kris Jenner getting a new face at 69 to Bryan Johnson, the infamous millionaire-turned-biohacker who does everything to reverse his biological age -- celebs' and social media influencers' obsession of looking young has led to a booming anti-ageing market. Data shows the anti-ageing market reached USD 122 billion in 2023 and is only expected to grow. This enormous market often influences people, especially women, to hold themselves to unrealistic beauty standards. Today, a 14-year-old starting anti-ageing treatments with retinol, documenting it all on social media, no longer surprises anyone. This trend has led to a phenomenon where Gen Zs are starting to look older than they actually are. But Why? These beauty standards and the need to look young are so normalised and ingrained in our brains that we rarely pause to ask the ultimate question -- why is looking and feeling 'young' so important? Neuroscientist Kumaar Bagrodia, founder of NeuroLeap and HALE, tells NDTV that in the modern brain, youth equals currency. "Neuroscience shows that youthful faces trigger key reward circuits -- like the ventral tegmental area and nucleus accumbens -- the same circuits activated by money, attention, and social validation," Bagrodia explains. He adds that the Default Mode Network (DMN), responsible for how we see ourselves and compare ourselves to others, is constantly processing social cues. In today's world, visual markers of youth signal power, vitality, and relevance. They tell everyone that we still belong. In parallel, the Salience Network (a collection of brain regions that helps identify and prioritise stimuli) tunes our attention to what society rewards. When filtered beauty, botox, and anti-ageing hacks dominate media feeds, the brain adapts and prioritises youth as a survival asset. "Looking young isn't just an aesthetic; it's a neuro-status signal. And in today's attention economy, youth wins the algorithm, the approval, and the influence," he adds. This obsession with looking young has not only created a multi-billion dollar market but has also led to a rise in anti-ageing treatments that, if not performed under expert supervision, can seriously harm your health, or even prove fatal. The Rise In Anti-Ageing Treatments NDTV spoke to various experts who all agreed that there's been a notable rise in anti-ageing treatments. "There has undoubtedly been a visible rise in demand for anti-ageing treatments. I have increasing numbers of patients seeking preventive dermatology, injectables like botox and fillers, and non-surgical procedures like lasers and RF therapy. Social media, increased awareness, and a desire to age well are strong driving factors," says Dr Chandani Jain Gupta, MBBS, MD, Dermatologist & Aesthetic Physician at Elantis Healthcare, New Delhi. Dr Ajay Rana, Dermatologist and Aesthetic Physician and Founder & Director of ILAMED, says this shift is part of a wider trend, "With advancements in cosmetic dermatology and a growing awareness of skin health, more people are turning to these treatments to address signs of ageing and maintain a youthful appearance." Dr Shweta Tripathi, Senior Consultant Dermatologist and Aesthetic Injector and Founder of My Skindom Skin Clinic, adds, "Everybody wants to look a certain way. Looking young is now accessible at your doorstep. People are extremely conscious about their fine lines and folds." According to experts, millennials and Gen Zs are increasingly starting preventive care early. Common treatments include: Botox, dermal fillers, chemical peels, laser resurfacing, PRP, and skin boosters Non-invasive options like HIFU (High-Intensity Focused Ultrasound) and Thermage for minimal downtime 'If Not Done Right, Anti-Ageing Can Go Dangerously Wrong' Dr Mahnaz Jahan Begum, Aesthetic Expert, Entrepreneur, Founder of Keradis and Medical Director at Aterm Clinics, Kolkata, says, "Anti-ageing therapies should always be tailored, monitored, and based on thorough diagnostics. What works for one body could be dangerous for another-especially if there are hidden heart issues." She highlights risks often ignored in casual or unmonitored settings: Hormone therapies like HRT or testosterone carry risks of heart attack, stroke, and blood clotting NAD+ infusions, growth hormone boosters, and metabolic enhancers can raise blood pressure and affect heart rhythm Stimulants for fat loss or energy can increase the risk of sudden cardiac events Dr Chandani Jain Gupta reiterates, "If anti-ageing treatments are not done correctly or by inexperienced hands, they can lead to serious complications like infection, scarring, or abnormal results." Dr Tripathi explains, "Injectables work on muscles and some fillers can migrate. If not done correctly, they can cause permanent damage." Dr Rana adds, "Poorly administered treatments may result in allergic reactions or unsatisfactory results. These are not quick-fix beauty hacks-they require clinical knowledge and precision." Biohacking: A Dangerous Influence On Younger Adults The recent explosion in biohacking trends; yet another anti-ageing treatment largely influenced by online content and celebrity wellness endorsements (read Bryan Johnson), has sparked concern. Today, the biohacking market is expected to reach USD 149.6 billion between 2025 and 2029, significantly impacting millennials and Gen Z, and their drive to look younger. View this post on Instagram A post shared by Bryan Johnson (@bryanjohnson_) Dr Begum describes biohacking as "a movement where people use science, supplements, wearables, and even prescription drugs to 'optimise' their bodies and slow ageing". But she warns that "there's a dangerous misconception that anything 'natural' or 'anti-ageing' is automatically safe". Dr Gupta notes that unsupervised biohacking carries several risks, including: Hormonal imbalances Nutrient depletion Sleep disruption "Anti-ageing treatments are no longer just about reversing time; they're about enhancing confidence, maintaining skin health, and ageing gracefully. But one must always follow pre- and post-care protocols for safe, long-lasting results," Dr Shikha Baghi, BDS, MDS, Founder and MD, Timeless Aesthetics, reminds us of the bigger picture as she concludes. The Fine Line The line between self-care and obsession is growing thinner, blurred by filters, pressure, and pseudo-science. While science continues to evolve and offer incredible ways to age gracefully, the cost of blindly following trends can be more than skin deep.
Economic Times
7 hours ago
- Economic Times
Wockhardt activates Zaynich push, eyes global licensing deals
Habil Khorakiwala Mumbai: Wockhardt is working on ambitious plans for Zaynich, a combination of zidebactam and cefepime that was found to be effective during clinical trials to fight superbugs or bacterial infections that show resistance to a range of existing antibiotic treatments. The drug maker has hired merchant bankers to identify possible out-licensing deals for the novel product, chairman Habil Khorakiwala told ET in an exclusive interview. Wockhardt in March sought regulatory approval for Zaynich in India and expects its commercial launch in the first half of '26. In the US, it plans to file for regulatory clearance in August.'We will get into the US market by the end of FY26 or latest by the second half of 2026 and Europe will be a year later,' Khorakiwala said. Zaynich is seen as a game-changing drug against drug-resistant gram-negative pathogens. These pathogens are difficult to kill. Zaynich is estimated to have a market opportunity of about $9 billion. Around a million people die due to multidrug resistance in India every year, while worldwide, the number is 5 million, Khorakiwala said. Currently there are very few effective treatments available for these infections. Mumbai-based Wockhardt completed the Phase-3 clinical trials for Zaynich earlier this year. In January it announced that the drug demonstrated more than 97% clinical efficacy in treating serious infections of bacteria resistant to carbapenem antibiotics, which are often used as a last resort to treat severe infections. The company is prepared to go solo to market Zaynich in India, the US and other markets if the licensing proposals do not meet its expectations on valuation, Khorakiwala said without revealing the valuation he is looking for.'We will evaluate how to go about and take an appropriate call, so we are keeping two options fully alive,' Khorakiwala said. 'One option is licensing out, the other is in some markets like in India we are doing ourselves,' he said. 'The US is another market where we are thinking of the possibility (of marketing on its own); you don't need too much marketing cost and you have talent available.'Wockhardt also plans to fully outsource manufacturing for the Western markets to eliminate issues related to the US Food and Drug Administration, and channel its focus on the clinical and research part.'For manufacturing, plenty of options are available in Europe and the US, so I am not getting into FDA-related manufacturing problems,' said Khorakiwala. 'Zaynich — we are manufacturing everything in Europe.' It will adopt the same strategy to outsource most of the manufacturing for all its other new company had in the past faced some issues with the US FDA over alleged violations of good manufacturing practices. 'That (FDA-elated manufacturing problems) was our weakness, and I am eliminating that completely from my western markets to only focus on the clinical and research part,' he said. COMPANY TURNAROUND Wockhardt has seen a remarkable turnaround in its stock price in the past year and a half with renewed confidence from investors, with developments on Zaynich being among the key drivers. Its stock price more than doubled in the last 12 months and increased over three-and-a-half times since January 2024. The shares closed at `1,713.20, up 4.5%, on BSE Monday. 'We have revisited what are the strengths and what are the opportunities — one obviously is our new drug discovery — in India and worldwide,' said also stressed on the company's focus on biologics as another key growth driver.'Within biologics we will stay in insulin and GLP1; we are not going to touch the rest of the biologics like monoclonal antibodies and others. Because we feel it is important to be focused,' he does not see itself as a generic company, he said. 'In fact, in the US we are exiting generics … we will be focused on the biological area and NCE (new chemical entities) and strictly on antibiotics,' he chairman said his research pipeline has a range of antibiotics under development, including early-stage work on an oral version of Zaynich. PRICING STRATEGY Khorakiwala said the treatment cost with most new products including antimicrobials launched in the last 10 years in the US has been in the range of $10,000-15,000 per treatment. Zaynich will also hover in that range in the US but in India, the price will be significantly lower, he said.
Time of India
11 hours ago
- Time of India
Govt doctors protest seeking action against official
Madurai: The Tamil Nadu Government Doctors Association (TNGDA) on Monday sought strict action against the deputy director of health services (DDHS), Madurai, following complaints of workplace harassment from medical officers. Earlier, a video clip of the official using unparliamentary language during an online meeting went viral on social media platforms. The protest was held after working hours. Protesters said they had submitted a complaint against the official earlier, but no action has been taken so far. TNGDA state president K Senthil told TOI that they received complaints from several doctors regarding the conduct of Dr P Kumaragurubaran. On May 17, a formal complaint was lodged with the director of public health regarding the same, and on May 24, an inquiry was conducted by the joint director of health services. Around 25 doctors appeared during the inquiry and gave statements, but no action has been taken, he said. "The DDHS is now using different coercive measures to insult doctors indirectly through other workers," he added. The TNGDA on Monday announced that doctors will boycott and avoid communication with Kumaragurubaran until disciplinary action is taken against him. "We have asked doctors to block him and not respond to him on WhatsApp and instead heed only orders issued through official circulars. Even leaves would be applied and submitted to the district health office by mail. No service to patients would be affected by the boycott. If our demand is not met, we will intensify the protest," Senthil added.
